TVTX
Travere Therapeutics·NASDAQ
--
--(--)
--
--(--)
3.05 / 10
Netural
Technical assessment gives TVTX a neutral 3.05/10 score. A MACD Golden Cross suggests bullish momentum (62.5% win, 5.16% avg return), but frequent MACD Death Crosses and long lower shadows generate bearish pressure, leaving the short‑term direction unclear.
Analysis Checks(1/3)
Long Lower Shadow
Score1/10
Win Rate35.00%
Hist. Signals20
Avg Return-1.11%
Score1/10
Win Rate35.00%
Hist. Signals20
Avg Return-1.11%
MACD Golden Cross
Score7.14/10
Win Rate62.50%
Hist. Signals8
Avg Return5.16%
Score7.14/10
Win Rate62.50%
Hist. Signals8
Avg Return5.16%
MACD Death Cross
Score1/10
Win Rate20.00%
Hist. Signals10
Avg Return-3.17%
Score1/10
Win Rate20.00%
Hist. Signals10
Avg Return-3.17%
Long Lower Shadow
Score1/10
Win Rate35.00%
Hist. Signals20
Avg Return-1.11%
Score1/10
Win Rate35.00%
Hist. Signals20
Avg Return-1.11%
MACD Death Cross
Score1/10
Win Rate20.00%
Hist. Signals10
Avg Return-3.17%
Score1/10
Win Rate20.00%
Hist. Signals10
Avg Return-3.17%
MACD Golden Cross
Score7.14/10
Win Rate62.50%
Hist. Signals8
Avg Return5.16%
Score7.14/10
Win Rate62.50%
Hist. Signals8
Avg Return5.16%
Technical Analysis of TVTX?
- TVTX presents a Netural setup with a Technical Score of 3.05/10. Key technical indicators highlight an RSI of 44.10 and a MACD of 0.16, with the trend anchored by the 50-Day SMA at 29.08. Traders should monitor key support at 26.92 and resistance at 28.77.
